Table 1

Main characteristics of the studies included in the systematic review

StudyN
(% male)
Age (year)Study designPatient categoryInclusion criteriaDuration of MV (day)DD measurementsDefinition of weaning failureOutcomes
Jiang et al 19 27 (49)67 (33–84)Prospective cohortMedical ICU patientsReceived MV and prepared for extubation after SBT11±6Displacement of the liver/spleenReintubation or NIMV within 72 hoursMean values of liver and spleen displacements (mm) were higher in the
SG than the FG (14.5±4.8 vs 8.4±3.9, p<0.001)
Kim et al 11 50 (61)66Prospective cohortMedical ICU patientsMV for 48 hours and passed SBTNon-DD, 8.4 (4.5–17) DD, 24 (15.5–35.4)DE (mm)MV within 48 hours of self-breathingPatients with DD had higher rates of primary (20 of 24
vs 34 of 58, p<0.01) and secondary weaning failures (10 of 20 vs 10 of 46, p<0.01)
DiNino et al 35 63 (49)66±19Prospective cohortMedical ICU patientsMV patients as ready to undergo a weaning trial or SBT5 (IQR4)DTReintubation within 48 hours or terminal extubation or tracheostomyThe combined sensitivity and specificity of Δtdi% ≥30% for extubation success was 88% and 71%, respectively
Ferrari et al 30 34 (74)54.6±12.1Prospective cohortMV patients received tracheostomy in a high- dependency unitReceived MV and underwent SBT28 (22–37)DTSBT failureDTF (%) was significantly different between the SG and the FG (56 (38–64) vs 26 (22–30), p<0.0001)
Ali and Mohamad 12 45 (75)54±11.23Prospective cohortMixed ICU patientsPatients had a likelihood of prolonged
(>72 hours) MV
8±13.22DE and DTMV within 48 hours of self-breathingSG presented higher DE (23 (19–28) vs 12 (9–14)), p<0.0001 and DTF (56 (35–63) vs 26 (22–33), p<0.0001)
Dres et al 13 52 (68)57±16Prospective cohortMedical ICU patientsMV for at least 24 hours and underwent SBT4 (2–6)DE and DTSBT failureSG presented higher DE (11.2±3.7 vs 8.2±4.2), p=0.01 and DTF (35±12
vs 19±9, p<0.001)
Gong and Zhang 27 32 (73)67.59±9.78Prospective cohortMixed ICU patientsMV for at least 24 hours and passed SBTSG (5.27±2.64) FG (6.64±2.68)DESBT failure or the need for reintubation, or NIMV or death within 48 hoursNo significant difference of
DE between SG and FG (15.8±5.2 vs 18.4±10.2, p>0.05)
Hu et al 20 34 (67)SG (59.2±12.5) FG (61.5±13.9)Prospective cohortMedical ICU patientsMV for at least 48 hoursSG, 4 (3.5) FG, 8 (7.8)DE and DTNot specifiedSG presented higher DE (17±6 vs 10±4, p<0.01) and DTF (32±22
vs 20±5, p=0.04)
Spadaro et al 21 31 (61)65±13Prospective cohortMixed ICU patientsMV for at least 48 hours at their first SBT69 (53–173)DESBT failure, reintubation, or NIMV within 48 hoursSG presented higher DE (15.5 (11.7–23.0) vs 7.0 (6.0–14.7), p<0.0001)
Farghaly and Hasan22 31 (57)SG, 65 (55–67.8) FG, 62.5 (55–70.7)Prospective cohortRespiratory ICU patientsReceived MV and passed SBTSG, 5 (4–5.7) FG, 5 (4–5.3)DE and DTInability to maintain spontaneous breathing without any ventilatory support within 48 hoursSG presented higher DE (16 (11.4–18) vs 9.8 (8.8–12), p<0.0001) and DTF (58.9 (38–84.3) vs 30.8 (22.3–85), p=0.021)
Xu et al 23 37 (60)SG (71.2±8.3), FG (73.1±7.4)Retrospective cohortRespiratory ICU patientsCOPD patients Received MV and underwent SBTSG (10.2±3.2), FG (14.5±4.6)DESBT failure, reintubation or NIMV within 48 hoursSG presented higher DE (12.6±3.4 vs 9.6±1.1, p<0.05)
  • COPD, chronic obstructive pulmonary disease; DD, diaphragmatic dysfunction; DE, diaphragmatic excursion; DT, diaphragm thickness; DTF, diaphragmatic thickening fraction; FG, failure group; ICU, intensive care unit; MV, mechanical ventilation; NIMV, non-invasive mechanical ventilation; SBT, spontaneous breathing trial; SG, success group.